Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Liabilities (2020 - 2025)

LifeStance Health (LFST) has disclosed Total Liabilities for 6 consecutive years, with $682.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 1.62% to $682.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $682.9 million, a 1.62% increase, with the full-year FY2025 number at $682.9 million, up 1.62% from a year prior.
  • Total Liabilities was $682.9 million for Q4 2025 at LifeStance Health, up from $656.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $720.0 million in Q3 2023 to a low of -$954.0 million in Q1 2021.
  • A 5-year average of $511.2 million and a median of $655.7 million in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 143.59% in 2022, then fell 6.83% in 2024.
  • LifeStance Health's Total Liabilities stood at $382.1 million in 2021, then soared by 71.47% to $655.1 million in 2022, then rose by 3.95% to $681.0 million in 2023, then dropped by 1.33% to $672.0 million in 2024, then increased by 1.62% to $682.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Total Liabilities are $682.9 million (Q4 2025), $656.2 million (Q3 2025), and $672.9 million (Q2 2025).